DeepMed Research

Cefprozil

Generic Name: Cefprozil

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₁₉N_₃O_₅S

CAS Number: 92665-29-7

Unique Ingredient Identifier: 1M698F4H4E

Background: Cefprozil is a cephalosporin antibiotic that is commonly employed to treat a variety of bacterial infections, including those of the ear and skin, bronchitis, and others.

Indication: For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph

Associated Conditions: Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Bacterial Infections, Community Acquired Pneumonia (CAP), Streptococcal Pharyngitis, Tonsillitis streptococcal, Urinary Tract Infection, Bacterial otitis media, Uncomplicated skin and subcutaneous tissue bacterial infections

Clinical Trials

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

Phase 4

Recruiting

Conditions: Community Acquired Pneumonia in Children

Interventions: Drug: Ampicillin for Injection
Drug: Ceftriaxone for Injection
Drug: Amoxicillin
Drug: Ampicillin / Sulbactam Injection
Drug: Amoxicillin-clavulanate
Drug: Clindamycin
Drug: Cefprozil
Drug: Levofloxacin

First Posted Date: 2024-07-10

Last Posted Date: 2024-11-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 236

Registration Number: NCT06494072

Locations: 🇺🇸
Childrens Wisconsin, Milwaukee, Wisconsin, United States

Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Cefprozil 125mg/5ml Susp; Cefprozil granule (125mg)

First Posted Date: 2020-06-04

Last Posted Date: 2020-06-04

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 60

Registration Number: NCT04414254

Locations: 🇨🇳
Phase I Clinical Research Center, Qingdao, Shandong, China

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb)
Drug: Cefprozil 500 mg Tablets (Sandoz GmbH)

First Posted Date: 2009-04-15

Last Posted Date: 2017-03-29

Lead Sponsor: Sandoz

Target Recruit Count: 26

Registration Number: NCT00881426

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefprozil 500 mg Tablets (Sandoz, GmbH)
Drug: Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb, USA)

First Posted Date: 2009-04-15

Last Posted Date: 2017-03-29

Lead Sponsor: Sandoz

Target Recruit Count: 35

Registration Number: NCT00881855

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefprozil 250 mg/5 ml Oral Suspension (Sandoz GmbH)
Drug: Cefzil (Cefprozil) 250 mg/5 ml Oral Suspension (Bristol-Myers Squibb)

First Posted Date: 2009-04-15

Last Posted Date: 2017-03-29

Lead Sponsor: Sandoz

Target Recruit Count: 20

Registration Number: NCT00881153

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefprozil 250 mg/5 ml Oral Suspension (Sandoz, Austria)
Drug: Cefzil (Cefprozil) 250 mg/5 ml Oral Suspension (Bristol-Myers Squibb, USA)

First Posted Date: 2009-04-15

Last Posted Date: 2017-03-29

Lead Sponsor: Sandoz

Target Recruit Count: 24

Registration Number: NCT00881400

Cefprozil 500 mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefprozil 500 mg Tablets
Drug: Cefzil® 500 mg tablets

First Posted Date: 2009-02-10

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 38

Registration Number: NCT00840281

Locations: 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States

Cefprozil 500 mg Tablets Under Fed Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: cefprozil
Drug: Cefzil®

First Posted Date: 2009-02-10

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 39

Registration Number: NCT00840866

Locations: 🇺🇸
Gateway Medical Research, Saint Charles, Missouri, United States

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: CEFZIL® for Oral Suspension 250 mg/5mL
Drug: Cefprozil for oral suspension 250 mg/5 mL

First Posted Date: 2009-02-03

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 26

Registration Number: NCT00835354

Locations: 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cefprozil for oral suspension 250 mg/5 mL
Drug: CEFZIL® for Oral Suspension 250 mg/5mL

First Posted Date: 2009-02-03

Last Posted Date: 2024-08-20

Lead Sponsor: Teva Pharmaceuticals USA

Target Recruit Count: 26

Registration Number: NCT00835614

Locations: 🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States
🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy